Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON)
NCT ID: NCT03200834
Last Updated: 2025-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
239 participants
INTERVENTIONAL
2017-01-25
2029-01-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
D2 vs D3 Lymph Node Dissection for Left Colon Cancer
NCT04364373
Analysis of Surgical and Oncologic Outcomes After Complete Mesocolic Excision or Non-complete Mesocolic Excision for Right-Sided Colon Cancer
NCT06684223
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy
NCT06049758
Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer
NCT02682589
The Intraoperative Technical Errors of Robotic vs. Laparoscopic Radical Right Hemiclectomy
NCT07138859
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
D2 lymph node dissection for right colon cancer
Hemicolectomy for right colon cancer with D2 lymph node dissection
Right Hemicolectomy with D2 lymph node dissection
Remove right part of colon with lymph node dissection №201, №202, №211, №212 (if present), №221,№222 (Japanese classification).
D3 lymph node dissection for right colon cancer
Hemicolectomy for right colon cancer with D3 lymph node dissection
Right Hemicolectomy with D3 lymph node dissection
Remove right part of colon with lymph node dissection №201, №202, № 203, №211, №212 (if present), №213 (if present) №221,№222, №223 (for hepatic flexure and proximal part of transverse colon cancer)(Japanese classification).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Right Hemicolectomy with D2 lymph node dissection
Remove right part of colon with lymph node dissection №201, №202, №211, №212 (if present), №221,№222 (Japanese classification).
Right Hemicolectomy with D3 lymph node dissection
Remove right part of colon with lymph node dissection №201, №202, № 203, №211, №212 (if present), №213 (if present) №221,№222, №223 (for hepatic flexure and proximal part of transverse colon cancer)(Japanese classification).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Colon cancer (only adenocarcinoma )
3. The tumor located between the cecum and the right 1/3 of transverse colon
4. Tumors T3,Т4а,b N0-2 (II-III stages)
5. Tolerance of chemotherapy
6. ECOG 0-2
Exclusion Criteria
2. Tumors T1-2 (I stage)
3. Complications of tumor (perforation and full bowel obstruction)
4. Previous radiotherapy or chemotherapy
5. Synchronous or metachronous tumors
6. Women during Pregnancy or breast feeding period
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Donetsk National Medical University
OTHER
I.M. Sechenov First Moscow State Medical University
OTHER
G.V. Bondar Republican Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vladimir Balaban, PhD
Role: STUDY_DIRECTOR
M.Gorky Donetsk National Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
G.V. Bondar Republican Cancer Center
Donetsk, , Ukraine
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Balaban V, Mutyk M, Bondarenko N, Zolotukhin S, Sovpel O, Sovpel I, Zykov D, Rublevskiy I, Klochkov M, Prado AP, He M, Tsarkov P. Comparison of D2 vs D3 lymph node dissection for RIght COloN cancer (RICON): study protocol for an international multicenter open-label randomized controlled trial. Trials. 2024 Jul 2;25(1):438. doi: 10.1186/s13063-024-08269-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.